Literature DB >> 14872045

The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994.

D S Knopman1, R C Petersen, S D Edland, R H Cha, W A Rocca.   

Abstract

The records-linkage system of the Rochester Epidemiology Project was used to ascertain incident cases of frontotemporal lobar degeneration (FTLD) in Rochester, MN, from 1990 through 1994. Four cases of FTLD were identified (all women); two were confirmed neuropathologically. All were of the behavioral-dysexecutive type and had onset before age 70. The incidence rates (new cases per 100,000 person-years) were 2.2 for ages 40 to 49, 3.3 for ages 50 to 59, and 8.9 for ages 60 to 69. For comparison, the corresponding rates for Alzheimer disease were 0.0, 3.3, and 88.9.

Entities:  

Mesh:

Year:  2004        PMID: 14872045     DOI: 10.1212/01.wnl.0000106827.39764.7e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  64 in total

1.  CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

Authors:  Francesca de Rino; Filippo Martinelli-Boneschi; Francesca Caso; Marta Zuffi; Matteo Zabeo; Gabriella Passerini; Giancarlo Comi; Giuseppe Magnani; Massimo Franceschi
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

2.  Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia.

Authors:  Andrea Slachevsky; Carlos Muñoz-Neira; Javier Nuñez-Huasaf; Theodore A Stern; Carl R Blesius; Alireza Atri
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples.

Authors:  Virginia E Sturm; Megan E McCarthy; Ira Yun; Anita Madan; Joyce W Yuan; Sarah R Holley; Elizabeth A Ascher; Adam L Boxer; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-29       Impact factor: 3.436

Review 4.  Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Authors:  Margaret Flanagan; Eric B Larson; Caitlin S Latimer; Brenna Cholerton; Paul K Crane; Kathleen S Montine; Lon R White; C Dirk Keene; Thomas J Montine
Journal:  Biochim Biophys Acta       Date:  2015-08-28

5.  Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman.

Authors:  Baber K Khan; Josh D Woolley; Steven Chao; Tricia See; Anna M Karydas; Bruce L Miller; Katherine P Rankin
Journal:  Psychosomatics       Date:  2012-01-28       Impact factor: 2.386

Review 6.  Young-onset dementia.

Authors:  Dulanji K Kuruppu; Brandy R Matthews
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 7.  Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology.

Authors:  Robert W Levenson; Virginia E Sturm; Claudia M Haase
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

8.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

9.  Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis.

Authors:  Brian B Avants; Philip A Cook; Lyle Ungar; James C Gee; Murray Grossman
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

Review 10.  The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Authors:  Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings
Journal:  Alzheimers Dement       Date:  2012-10-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.